THALIDOMIDE AND KETOPROFEN REDUCE THE INCIDENCE OF ADVERSE EVENTS OF INTERLEUKIN-2 AND ENHANCE THE ANTIVIRAL ACTIVITY OF CD8 IN HIV AIDS PATIENTS/

Authors
FEREGRINOGOYOS M GOMEZCARO WH ALVARADODIEZ R YIEYRA MPM TORRASGINER V
Citation
M. Feregrinogoyos et al., THALIDOMIDE AND KETOPROFEN REDUCE THE INCIDENCE OF ADVERSE EVENTS OF INTERLEUKIN-2 AND ENHANCE THE ANTIVIRAL ACTIVITY OF CD8 IN HIV AIDS PATIENTS/, AIDS, 10, 1996, pp. 60-60
Citations number
NO
Categorie Soggetti
Immunology,"Infectious Diseases
Journal title
AIDS → ACNP
ISSN journal
02699370
Volume
10
Year of publication
1996
Supplement
2
Pages
60 - 60
Database
ISI
SICI code
0269-9370(1996)10:<60:TAKRTI>2.0.ZU;2-O